Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22.3M
-
Number of holders
-
225
-
Total 13F shares, excl. options
-
19.9M
-
Shares change
-
+681K
-
Total reported value, excl. options
-
$1.33B
-
Value change
-
+$48.4M
-
Put/Call ratio
-
1.68
-
Number of buys
-
107
-
Number of sells
-
-92
-
Price
-
$66.95
Significant Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q1 2025
249 filings reported holding ANIP - ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share as of Q1 2025.
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) has 225 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.9M shares
of 22.3M outstanding shares and own 89.49% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (2.65M shares), VANGUARD GROUP INC (1.18M shares), MILLENNIUM MANAGEMENT LLC (818K shares), Global Alpha Capital Management Ltd. (736K shares), CITADEL ADVISORS LLC (723K shares), STATE STREET CORP (715K shares), Deep Track Capital, LP (700K shares), GOLDMAN SACHS GROUP INC (632K shares), DIMENSIONAL FUND ADVISORS LP (632K shares), and Ranger Investment Management, L.P. (572K shares).
This table shows the top 225 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.